Nisen Perry (CIK 1683791) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy TEVA (14,492 shares), Buy TEVA (9,632 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | Buy | 14,492 | $0 |
| 2025-06-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | Buy | 9,632 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08